(Q35932342)

11 August 2017

1 reference

title

Postmenopausal hormone therapy before and after the women's health initiative study: what consequences? (English)

1 reference

11 August 2017

Tomi S Mikkola

1

1 reference

11 August 2017

Thomas B Clarkson

series ordinal

2

1 reference

11 August 2017

Morris Notelovitz

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

36

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

402-413

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

11 August 2017

1 reference

Factors affecting sexual functioning of women in the mid-life years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Hormone therapy to prevent disease and prolong life in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Menopause and risk of cardiovascular disease: the Framingham study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

A prospective study of postmenopausal estrogen therapy and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

MPA and postmenopausal coronary artery atherosclerosis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Estrogen plus progestin and the risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Effects of hormone replacement therapy on plaque stability, inflammation, and fibrinolysis in hypertensive or overweight postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Hormone replacement therapy is associated with less coronary atherosclerosis in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Estrogen plus progestin and colorectal cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Effects of estrogen plus progestin on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Postmenopausal hormones--therapy for symptoms only

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Estradiol absorption from vaginal tablets in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Estrogen replacement therapy, atherosclerosis, and vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

Prospective study of exogenous hormones and risk of pulmonary embolism in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890410035430

10.1080/07853890410035430

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference